| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AACR/Japanese cancer association
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 2 |
A case control study of factors associated with macroscopic breast cysts
|
Gateley, Christopher A.
|
|
1992
|
28 |
1 |
p. 125-127
3 p.
|
article
|
| 3 |
A cell line with unusual characteristics from an ovarian carcinoma patient: Modulation of sensitivity to antitumour drugs
|
Wasserman, Lina
|
|
1992
|
28 |
1 |
p. 22-27
6 p.
|
article
|
| 4 |
Adequate tumour quinidine levels for multidrug resistance modulation can be achieved in vivo
|
Wishart, Gordon C.
|
|
1992
|
28 |
1 |
p. 28-31
4 p.
|
article
|
| 5 |
A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour
|
Veenhof, Cees H.N.
|
|
1992
|
28 |
1 |
p. 75-78
4 p.
|
article
|
| 6 |
American radium society
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 7 |
Analysis of expressed N-ras mutations in human melanoma short-term cell lines with allele specific restriction analysis induced by the polymerase chain reaction
|
O'Mara, Shaun M.
|
|
1992
|
28 |
1 |
p. 9-11
3 p.
|
article
|
| 8 |
Antibody therapy of malignancy
|
Dyer, M.J.S.
|
|
1992
|
28 |
1 |
p. 276-280
5 p.
|
article
|
| 9 |
Approaches to proto-oncogene and tumour suppressor gene identification
|
Patterson, Helen
|
|
1992
|
28 |
1 |
p. 258-263
6 p.
|
article
|
| 10 |
A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy
|
Bishop, James F.
|
|
1992
|
28 |
1 |
p. 47-50
4 p.
|
article
|
| 11 |
BCL2 gene: Current relevance to clinical oncology
|
Brada, Michael
|
|
1992
|
28 |
1 |
p. 270-272
3 p.
|
article
|
| 12 |
Cancer development: the rise of epigenetics
|
Rubin, H
|
|
1992
|
28 |
1 |
p. 1-2
2 p.
|
article
|
| 13 |
Cancer prevention in Central and Eastern Europe
|
Bodmer, W.
|
|
1992
|
28 |
1 |
p. 4-7
4 p.
|
article
|
| 14 |
Cell and tissue responses of a murine tumour to phthalocyanine-mediated photodynamic therapy
|
van Bruggen, Nicholas
|
|
1992
|
28 |
1 |
p. 42-46
5 p.
|
article
|
| 15 |
Cerebrovascular accident associated with chemotherapy for oesophageal carcinoma
|
Gandia, Daniel
|
|
1992
|
28 |
1 |
p. 245-
1 p.
|
article
|
| 16 |
Clinical hyperthermia
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 17 |
Comparison of questionnaire-derived and tumour registry-derived smoking histories
|
Mayer, Jack L.
|
|
1992
|
28 |
1 |
p. 116-117
2 p.
|
article
|
| 18 |
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II study
|
Postmus, P.E.
|
|
1992
|
28 |
1 |
p. 96-100
5 p.
|
article
|
| 19 |
Corrections
|
|
|
1992
|
28 |
1 |
p. 246-
1 p.
|
article
|
| 20 |
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP
|
Steinke, B.
|
|
1992
|
28 |
1 |
p. 100-104
5 p.
|
article
|
| 21 |
Cytokine modulation of cell growth and role in tumour therapy
|
Patel, Poulam M.
|
|
1992
|
28 |
1 |
p. 298-302
5 p.
|
article
|
| 22 |
Differentiation and cancer
|
Mason, M.D.
|
|
1992
|
28 |
1 |
p. 255-258
4 p.
|
article
|
| 23 |
DNA damage by drugs and radiation: What is important and how is it measured?
|
Whitaker, Stephen J.
|
|
1992
|
28 |
1 |
p. 273-276
4 p.
|
article
|
| 24 |
EACH-II—The European Association for Cancer Research meet in Italy
|
Price, Michael R.
|
|
1992
|
28 |
1 |
p. 239-240
2 p.
|
article
|
| 25 |
Editorial Board
|
|
|
1992
|
28 |
1 |
p. IFC-
1 p.
|
article
|
| 26 |
Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration
|
Troger, V.
|
|
1992
|
28 |
1 |
p. 82-86
5 p.
|
article
|
| 27 |
EGF receptor amplification and expression in human brain tumours
|
Chaffanet, Max
|
|
1992
|
28 |
1 |
p. 11-17
7 p.
|
article
|
| 28 |
Endoscopic approaches to cancer diagnosis and treatment
|
Spinelli, Pasquale
|
|
1992
|
28 |
1 |
p. 236-
1 p.
|
article
|
| 29 |
EORTC General Assembly-1991 report on basic science research groups
|
Leake, Robin
|
|
1992
|
28 |
1 |
p. 237-239
3 p.
|
article
|
| 30 |
Flow cytometry
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 31 |
Glossary
|
Rocques, P.
|
|
1992
|
28 |
1 |
p. 302-307
6 p.
|
article
|
| 32 |
Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue
|
Walker, K.J.
|
|
1992
|
28 |
1 |
p. 34-37
4 p.
|
article
|
| 33 |
High frequency of tumour cell reversion to non-tumorigenic phenotype
|
Lavrovsky, Vadim A
|
|
1992
|
28 |
1 |
p. 17-21
5 p.
|
article
|
| 34 |
How are cancer associated genes activated or inactivated?
|
Wiedemann, Leanne M
|
|
1992
|
28 |
1 |
p. 248-251
4 p.
|
article
|
| 35 |
Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression
|
Gusterson, Barry A
|
|
1992
|
28 |
1 |
p. 263-267
5 p.
|
article
|
| 36 |
Incidence and mortality of breast cancer related to body height and living conditions during childhood and adolescence
|
Vatten, Lars J.
|
|
1992
|
28 |
1 |
p. 128-131
4 p.
|
article
|
| 37 |
Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor
|
Gurney, H
|
|
1992
|
28 |
1 |
p. 105-112
8 p.
|
article
|
| 38 |
In vitro growth ability and chemosensitivity of gastric and colorectal cancer cells assessed with the human tumour clonogenic assay and the thymidine incorporation assay
|
Tanigawa, Nobuhiko
|
|
1992
|
28 |
1 |
p. 31-34
4 p.
|
article
|
| 39 |
Malignant melanoma: Treatment of metastatic meningitis with intrathecal interferon alpha-2b
|
Dorval, T.
|
|
1992
|
28 |
1 |
p. 244-245
2 p.
|
article
|
| 40 |
Melatonin and the pineal gland
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 41 |
Meningeal fluid granulocytosis after cytarabine
|
Flasshove, M.
|
|
1992
|
28 |
1 |
p. 243-
1 p.
|
article
|
| 42 |
Mitozantrone-induced onycholysis
|
Mitchell, Paul L.R.
|
|
1992
|
28 |
1 |
p. 243-244
2 p.
|
article
|
| 43 |
Molecular biology for clinical oncologists
|
|
|
1992
|
28 |
1 |
p. 247-
1 p.
|
article
|
| 44 |
Multistage carcinogenesis in paediatric and adult cancers
|
Mitchell, Christopher
|
|
1992
|
28 |
1 |
p. 296-298
3 p.
|
article
|
| 45 |
Negative phase II study with carboplatin and 5-fluorouracil in advanced breast cancer
|
Palacio, I.
|
|
1992
|
28 |
1 |
p. 242-
1 p.
|
article
|
| 46 |
Nutrients and cancer prevention
|
Boyle, P.
|
|
1992
|
28 |
1 |
p. 236-
1 p.
|
article
|
| 47 |
POMB ACE chemotherapy in non-seminomatous germ cell tumours: Outcome and importance of dose intensity
|
Husband, David J
|
|
1992
|
28 |
1 |
p. 86-91
6 p.
|
article
|
| 48 |
Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin
|
Erba, Eugenio
|
|
1992
|
28 |
1 |
p. 66-71
6 p.
|
article
|
| 49 |
Quality control of cathepsin-D measurement by the EORTC receptor study group
|
Benraad, Theo J
|
|
1992
|
28 |
1 |
p. 72-75
4 p.
|
article
|
| 50 |
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial
|
Hürny, Christoph
|
|
1992
|
28 |
1 |
p. 118-124
7 p.
|
article
|
| 51 |
Radiation of jejunal interposition in T3–T4 upper aerodigestive tumours
|
Handl-Zeller, Leonore
|
|
1992
|
28 |
1 |
p. 50-53
4 p.
|
article
|
| 52 |
Relation between steroid receptor status and body weight in breast cancer patients
|
Giuffrida, Dario
|
|
1992
|
28 |
1 |
p. 112-115
4 p.
|
article
|
| 53 |
Residual DNA damage: What is left over and how does this determine cell fate?
|
McMillan, Trevor J
|
|
1992
|
28 |
1 |
p. 267-269
3 p.
|
article
|
| 54 |
Savings obtained by CA-125 measurements during therapy for ovarian carcinoma
|
Rustin, G.J.S.
|
|
1992
|
28 |
1 |
p. 79-82
4 p.
|
article
|
| 55 |
Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha
|
Lissoni, P.
|
|
1992
|
28 |
1 |
p. 92-96
5 p.
|
article
|
| 56 |
Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer
|
de Gramont, Aimery
|
|
1992
|
28 |
1 |
p. 53-58
6 p.
|
article
|
| 57 |
Serum ferritin levels in lung cancer patients
|
Ferrigno, Domenico
|
|
1992
|
28 |
1 |
p. 241-
1 p.
|
article
|
| 58 |
Specific binding of anti-N-acetyllactosamine monoclonal antibody 1B2 to acute myeloid leukaemia cells
|
Campos, Lydia
|
|
1992
|
28 |
1 |
p. 37-41
5 p.
|
article
|
| 59 |
Symposium on new drugs
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 60 |
The effect of timing of vincristine administration during a course of fractionated radiotherapy in a mouse carcinoma
|
Zanelli, Giuseppe D.
|
|
1992
|
28 |
1 |
p. 64-66
3 p.
|
article
|
| 61 |
The PCR revolution
|
Eeles, Rosalind A.
|
|
1992
|
28 |
1 |
p. 289-293
5 p.
|
article
|
| 62 |
The p53 gene in human cancer
|
Stratton, M.R.
|
|
1992
|
28 |
1 |
p. 293-295
3 p.
|
article
|
| 63 |
The role of DNA repair processes in determining response to cancer therapy
|
Ross, Gillian
|
|
1992
|
28 |
1 |
p. 281-285
5 p.
|
article
|
| 64 |
17th Gray conference
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 65 |
Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants
|
McIntyre, Catherine A.
|
|
1992
|
28 |
1 |
p. 58-63
6 p.
|
article
|
| 66 |
Trends in cancer mortality in Europe
|
Boyle, Peter
|
|
1992
|
28 |
1 |
p. 7-8
2 p.
|
article
|
| 67 |
Trends of cancer mortality in europe, 1955–1989: I, digestive sites
|
Vecchia, Carlo La
|
|
1992
|
28 |
1 |
p. 132-235
104 p.
|
article
|
| 68 |
Tumors of the lung
|
Corrin, B.
|
|
1992
|
28 |
1 |
p. 237-
1 p.
|
article
|
| 69 |
Tumour immunology course
|
|
|
1992
|
28 |
1 |
p. 240-
1 p.
|
article
|
| 70 |
Tumour markers for ovarian cancer
|
Rustin, Gordon J.S.
|
|
1992
|
28 |
1 |
p. 2-3
2 p.
|
article
|
| 71 |
Understanding anticancer drug resistance: Opportunities for modulation and impact on new drug design
|
Judson, Ian R
|
|
1992
|
28 |
1 |
p. 285-289
5 p.
|
article
|
| 72 |
Understanding DNA damage and repair: How useful will it be clinically?
|
Cassoni, Anna M.
|
|
1992
|
28 |
1 |
p. 247-248
2 p.
|
article
|
| 73 |
What are cancer genes, and how do they upset cell behaviour?
|
Yarnold, J.R.
|
|
1992
|
28 |
1 |
p. 251-255
5 p.
|
article
|
Journal description